ID | Name | Number of studies | |
---|---|---|---|
CL_0000576 | monocyte | 38 | |
CL_0002393 | intermediate monocyte | 7 |
Gene | Number of supported studies | Average coverage | Other major groups (express this gene) | Other cell types (express this gene) | |
---|---|---|---|---|---|
APOBEC3A | 5 | 39% ± 20% | 0 | 4 | |
LILRB2 | 5 | 62% ± 24% | 0 | 10 | |
NCF2 | 5 | 55% ± 23% | 0 | 10 | |
SLC11A1 | 5 | 58% ± 22% | 0 | 11 | |
LILRA5 | 4 | 63% ± 15% | 0 | 8 | |
CFP | 4 | 73% ± 9% | 0 | 10 | |
FPR1 | 4 | 68% ± 13% | 0 | 10 | |
CD300E | 3 | 58% ± 14% | 0 | 5 | |
IRF5 | 3 | 23% ± 7% | 0 | 6 | |
C19orf38 | 3 | 53% ± 16% | 0 | 6 | |
S100A12 | 3 | 59% ± 22% | 0 | 7 | |
MCOLN1 | 3 | 25% ± 5% | 0 | 8 | |
TREM1 | 3 | 38% ± 6% | 0 | 9 | |
NLRP3 | 3 | 41% ± 13% | 0 | 10 | |
ADGRE2 | 3 | 49% ± 5% | 0 | 11 | |
FCN1 | 6 | 75% ± 21% | 1 | 11 | |
CD163 | 5 | 44% ± 13% | 1 | 14 | |
CLEC7A | 5 | 62% ± 16% | 1 | 15 | |
MS4A7 | 5 | 56% ± 20% | 1 | 15 | |
FCGR3A | 5 | 46% ± 20% | 1 | 21 | |
PILRA | 4 | 49% ± 21% | 1 | 13 | |
IGSF6 | 4 | 51% ± 10% | 1 | 15 | |
C5AR1 | 6 | 49% ± 23% | 2 | 14 | |
MS4A6A | 6 | 58% ± 17% | 2 | 18 | |
IFI30 | 5 | 62% ± 22% | 2 | 17 | |
CYBB | 5 | 69% ± 9% | 2 | 19 | |
MPEG1 | 4 | 56% ± 20% | 2 | 14 | |
MNDA | 6 | 47% ± 23% | 3 | 14 | |
CD14 | 6 | 59% ± 20% | 3 | 18 | |
CSTA | 5 | 68% ± 27% | 3 | 20 |
GO_0006002 | Biological process | fructose 6-phosphate metabolic process |
GO_0046827 | Biological process | positive regulation of protein export from nucleus |
GO_0032727 | Biological process | positive regulation of interferon-alpha production |
GO_2001199 | Biological process | negative regulation of dendritic cell differentiation |
GO_0140105 | Biological process | interleukin-10-mediated signaling pathway |
GO_0032494 | Biological process | response to peptidoglycan |
Cell type name | intermediate monocyte |
Synonyms | |
Description | A monocyte that has characteristics of both patrolling and inflammatory monocytes. |
Parent | CL_0000576 |